Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose?
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a consequence, primaquine is currently either administered in many women with a relatively high risk of hemolysis (in countries where treatment is dependent on RDT testing) [5], or it is not given at all due to safety concerns [18] in a large proportion of the population.”
From Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood (2018) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malaria: progress, perils, and prospects for eradication
Greenwood, B. M., Fidock, D. A., Kyle, D. E., Kappe, S. H. I., Alonso, P. L., Collins, F. H., & Duffy, P. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33996 · Cited by 709
The changing epidemiology of malaria elimination: New strategies for new challenges
Cotter, C., Sturrock, H. J., Hsiang, M. S., Liu, J., Phillips, A. A., Hwang, J., Gueye, C. S., Fullman, N., Gosling, R. D., & Feachem, R. G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60310-4 · Cited by 671
Self-citation
Research works printed but not linked: 30
- WHO, 2013, World Malaria Report 2013
- Bousema T, 2011, Clin Microbiol Rev, 24, 377, 10.1128/CMR.00051-10 · DOI · Paper page
- White NJ, 2013, Lancet, 13, 175, 10.1016/S1473-3099(12)70198-6 · DOI
- Okell LC, 2012, Nat Commun, 3, 1237, 10.1038/ncomms2241 · DOI · Paper page
- Baird JK, 2010, Lancet, 376, 1883, 10.1016/S0140-6736(10)61494-8 · DOI
- Recht J, 2014, Safety of 8-aminoquinoline antimalarial medicines
- 10.1016/S0140-6736(08)60073-2 · DOI · Paper page
- Mueller O, 2013, Pharmacoepidemiol Drug Saf, 22, 376, 10.1002/pds.3370 · DOI
- 10.1086/324081 · DOI · Paper page
- Guttmann P, 1891, Berlin Klin Wochenschr, 28, 953
- Avula B, 2013, J Mass Spec, 48, 276, 10.1002/jms.3122 · doi:10.1002/jms.3122
- WHO Working Group, 1989, Bull World Health Organ, 67, 601
- Howes RE, 2012, PLoS Med, 9, e1001339, 10.1371/journal.pmed.1001339 · DOI · Paper page
- Leslie T, 2010, PLoS Med, 7, e1000283, 10.1371/journal.pmed.1000283 · DOI · Paper page
- Ruwende C, 1995, Nature, 376, 246, 10.1038/376246a0 · DOI · Paper page
- Graves PM, 2012, Cochrane Database Syst Rev, 9, CD008152
- Graves PM, 2014, Cochrane Database Syst Rev, 6, CD008152
- 10.1016/B978-0-12-407826-0.00004-7 · DOI · Paper page
- White NJ, 2012, Malar J, 11, 418, 10.1186/1475-2875-11-418 · DOI · Paper page
- Rieckmann KH, 1968, Bull World Health Organ, 38, 625
- 10.1016/S1473-3099(13)70268-8 · DOI
- Bennett JW, 2013, N Engl J Med, 269, 1381, 10.1056/NEJMc1301936 · DOI · Paper page
- Pybus BS, 2013, Malar J, 12, 212, 10.1186/1475-2875-12-212 · DOI · Paper page
- Shekalaghe SA, 2010, Antimicrob Agents Chemother, 54, 1762, 10.1128/AAC.01135-09 · DOI
- Shekalaghe S, 2007, PLoS One, 10, e1023, 10.1371/journal.pone.0001023 · DOI · Paper page
- Cui L, 2012, Acta Trop, 121, 240, 10.1016/j.actatropica.2011.04.006 · DOI
- Fernando D, 2011, Malar J, 10, 351, 10.1186/1475-2875-10-351 · DOI · Paper page
- Eziefula AC, 2012, Malar J, 11, 360, 10.1186/1475-2875-11-360 · DOI · Paper page
- Howes RE, 2013, Malaria J, 12, 418, 10.1186/1475-2875-12-418 · DOI · Paper page
- Johnston GL, 2014, PLoS Comput, 10, e1003434, 10.1371/journal.pcbi.1003434 · DOI
Cited by
Bancone, G., Gornsawun, G., Chu, C. S., Porn, P., Pal, S., Bansil, P., Domingo, G. J., & Nosten, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196716 · Cited by 65
Metadata
- Authors
- Chen, I. T., & Gosling, R. D.
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2014-08-13
- Volume
- 7
- Issue
- 6
- Pages
- 681-686
- ISSN
- 1751-2433
- 1751-2441
- Cited by
- 9
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose? https://app.cochat.ai/papers/10.1586/17512433.2014.948421
- The paper
- Chen, I. T., & Gosling, R. D. (2014). Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose? Expert Review of Clinical Pharmacology. https://doi.org/10.1586/17512433.2014.948421
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.